{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T03:21:30Z","timestamp":1792466490397,"version":"4.5.0"},"reference-count":27,"publisher":"American Association for the Advancement of Science (AAAS)","issue":"122","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Sci. Transl. Med."],"published-print":{"date-parts":[[2012,2,22]]},"abstract":"<jats:p>Implanted in humans, a wirelessly controlled, microchip-based drug delivery device demonstrates pharmacokinetic profiles of an anti-osteoporosis drug that are similar to subcutaneous injections.<\/jats:p>","DOI":"10.1126\/scitranslmed.3003276","type":"journal-article","created":{"date-parts":[[2012,2,17]],"date-time":"2012-02-17T05:31:02Z","timestamp":1329456662000},"source":"Crossref","is-referenced-by-count":404,"title":["First-in-Human Testing of a Wirelessly Controlled Drug Delivery Microchip"],"prefix":"10.1126","volume":"4","author":[{"given":"Robert","family":"Farra","sequence":"first","affiliation":[{"name":"MicroCHIPS, Inc., Waltham, MA 02451, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"Norman F.","family":"Sheppard","sequence":"additional","affiliation":[{"name":"MicroCHIPS, Inc., Waltham, MA 02451, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"McCabe","sequence":"additional","affiliation":[{"name":"MicroCHIPS, Inc., Waltham, MA 02451, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert M.","family":"Neer","sequence":"additional","affiliation":[{"name":"Endocrine Unit, Massachusetts General Hospital, Harvard Medical School, Boston, MA 02114, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M.","family":"Anderson","sequence":"additional","affiliation":[{"name":"Department of Pathology, Case Western Reserve University, Cleveland, OH 44106, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"John T.","family":"Santini","sequence":"additional","affiliation":[{"name":"On Demand Therapeutics Inc., Tyngsboro, MA 01879, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Cima","sequence":"additional","affiliation":[{"name":"Department of Materials Science and Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Langer","sequence":"additional","affiliation":[{"name":"Department of Chemical Engineering, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"221","reference":[{"key":"e_1_3_2_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa032441"},{"key":"e_1_3_2_3_2","doi-asserted-by":"publisher","DOI":"10.1038\/16898"},{"key":"e_1_3_2_4_2","doi-asserted-by":"publisher","DOI":"10.1038\/nmat998"},{"key":"e_1_3_2_5_2","doi-asserted-by":"publisher","DOI":"10.1038\/nbt1199"},{"key":"e_1_3_2_6_2","unstructured":"J. R. Coppeta K. Shelton N. F. Sheppard Jr. D. Snell C. M. B. Santini Compression and cold weld sealing methods and devices U.S. Patent 2006\/0115323 A1 (2006)."},{"key":"e_1_3_2_7_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jconrel.2005.09.035"},{"key":"e_1_3_2_8_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-007-9243-2"},{"key":"e_1_3_2_9_2","doi-asserted-by":"publisher","DOI":"10.1007\/s11095-008-9544-0"},{"key":"e_1_3_2_10_2","doi-asserted-by":"publisher","DOI":"10.1016\/1054-8807(93)90060-F"},{"key":"e_1_3_2_11_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbm.a.30313"},{"key":"e_1_3_2_12_2","first-page":"13","article-title":"Explanted pacemakers: Observations of the long-term foreign body response.","volume":"7","author":"Perry L.","year":"2007","unstructured":"Perry L., Karp F., Hauch K., Ratner B. D., Explanted pacemakers: Observations of the long-term foreign body response. J. Undergrad. Res. Bioeng. 7, 13\u201321 (2007).","journal-title":"J. Undergrad. Res. Bioeng."},{"key":"e_1_3_2_13_2","unstructured":"WHO Scientific Group on the Assessment of Osteoporosis at Primary Health Care Level Summary Meeting Report Brussels Belgium 5-7 May 2004 (WHO Press Geneva Switzerland 2007)."},{"key":"e_1_3_2_14_2","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.061113"},{"key":"e_1_3_2_15_2","unstructured":"Eli Lilly and Co. Annual Report and Proxy Statement ; http:\/\/investor.lilly.com\/annuals.cfm."},{"key":"e_1_3_2_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/jbmr.5650070110"},{"key":"e_1_3_2_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/endo.138.11.5505"},{"key":"e_1_3_2_18_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(03)00202-3"},{"key":"e_1_3_2_19_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM200105103441904"},{"key":"e_1_3_2_20_2","doi-asserted-by":"publisher","DOI":"10.1016\/S8756-3282(00)00430-0"},{"key":"e_1_3_2_21_2","unstructured":"K. Taylor D. T. Gold P. Miller P. Chen M. Wong K. Krohn Teriparatide therapy in a community setting: Persistence and use of other osteoporosis medications in DANCE paper presented at the 30th Annual Meeting of the American Society for Bone and Mineral Research 2008."},{"key":"e_1_3_2_22_2","unstructured":"H. Y. Ahn Clinical Pharmacology and Biopharmaceutics Review (Food and Drug Administration Center for Drug Evaluation and Research Silver Spring MD 2002); http:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/nda\/2002\/21-318_FORTEO_BioPharmr.pdf."},{"key":"e_1_3_2_23_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMcpc049016"},{"key":"e_1_3_2_24_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.matsci.31.1.81"},{"key":"e_1_3_2_25_2","unstructured":"Food and Drug Administration Center for Drug Evaluation and Research Guidance for Industry: Statistical Approaches to Establishing Bioequivalence (Food and Drug Administration Silver Spring MD 2001); http:\/\/www.fda.gov\/downloads\/Drugs\/GuidanceComplianceRegulatoryInformation\/Guidances\/UCM070244.pdf."},{"key":"e_1_3_2_26_2","unstructured":"European Medicines Agency Committee for Medicinal Products for Human Use Guideline on the Investigation of Bioequivalence (European Medicines Agency London UK 2009)."},{"key":"e_1_3_2_27_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.bone.2009.07.091"},{"key":"e_1_3_2_28_2","unstructured":"Immutopics Inc. High Sensitivity Human PTH (1-34) ELISA Kit; http:\/\/www.immutopics.com\/pdf\/directional-inserts\/60-3900.pdf."}],"container-title":["Science Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.science.org\/doi\/pdf\/10.1126\/scitranslmed.3003276","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,16]],"date-time":"2024-01-16T18:28:35Z","timestamp":1705429715000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.science.org\/doi\/10.1126\/scitranslmed.3003276"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2,22]]},"references-count":27,"journal-issue":{"issue":"122","published-print":{"date-parts":[[2012,2,22]]}},"alternative-id":["10.1126\/scitranslmed.3003276"],"URL":"https:\/\/doi.org\/10.1126\/scitranslmed.3003276","relation":{},"ISSN":["1946-6234","1946-6242"],"issn-type":[{"value":"1946-6234","type":"print"},{"value":"1946-6242","type":"electronic"}],"subject":[],"published":{"date-parts":[[2012,2,22]]}}}